Your browser doesn't support javascript.
loading
Investigation of the frequency of COVID-19 in patients treated with intravesical BCG
Karabay, Oğuz; Köse, Osman; Tocoglu, Aysel; Uysal, Burak; Dheir, Hamad; Yaylaci, Selcuk; Guclu, Ertugrul.
  • Karabay, Oğuz; Sakarya University. Faculty of Medicine. Department of Infectious Diseases. Sakarya. TR
  • Köse, Osman; Sakarya University. Education and Research Hospital. Department of Urology. Sakarya. TR
  • Tocoglu, Aysel; Sakarya University. Faculty of Medicine. Department of Internal Medicine. Sakarya. TR
  • Uysal, Burak; Sakarya University. Education and Research Hospital. Department of Urology. Sakarya. TR
  • Dheir, Hamad; Sakarya University. Faculty of Medicine. Department of Internal Medicine. Sakarya. TR
  • Yaylaci, Selcuk; Sakarya University. Faculty of Medicine. Department of Internal Medicine. Sakarya. TR
  • Guclu, Ertugrul; Sakarya University. Faculty of Medicine. Department of Infectious Diseases. Sakarya. TR
Rev Assoc Med Bras (1992) ; 66(Suppl 2): 91-95, 2020. tab, graf
Article in English | SES-SP, LILACS | ID: biblio-1136387
ABSTRACT
SUMMARY INTRODUCTION In this retrospective study, we aimed to investigate the frequency of COVID-19 in patients with and without BCG application due to bladder tumors. METHODS The presence of COVID-19 was investigated in 167 patients with BCG and 167 without bladder cancer. All patients were compatible with COVID-19 infection. Patients with RT-PCR positive for SARS-CoV-2 and/or Chest CT positive for viral pneumonia between March and May 2020 were included in the study. RESULTS A total of 334 patients were included in the study. The mean age of the 167 patients in the study group was 71.1±14.2 1 (min. 38.0- max. 98.0 years), 141 (84.4%) were male. The mean age of the 167 patients in the control group was 70.5±13.8 years (min. 41.0- max. 96.0 years), and 149 were male (p> 0.05). COVID-19 was detected in 5 patients in the BCG group and in 4 patients in the control group (P> 0.05). CONCLUSION Intravesical BCG administration does not decrease the frequency of COVID-19 infection.
RESUMO
RESUMO INTRODUÇÃO Neste estudo retrospectivo, objetivou-se investigar a frequência de COVID-19 em pacientes com e sem aplicação de BCG por tumor de bexiga. MÉTODOS A presença de COVID-19 foi investigada em 167 pacientes com BCG e 167 sem câncer de bexiga. Todos os pacientes compatíveis para infecção por COVID-19. Resumidamente, os pacientes foram incluídos no estudo com RT-PCR positivo para Sars-CoV-2 e/ou TC de tórax positivo para pneumonia viral entre março e maio de 2020. RESULTADOS Um total de 334 pacientes foi incluído no estudo. A idade média dos 167 pacientes no grupo de estudo foi de 71,1±14,2 1 (min. 38,0 - máx. 98,0 anos), 141 (84,4%) eram do sexo masculino; 167 pacientes do grupo controle tinham idade média de 70,5±13,8 (min. 41,0 - máx. 96,0 anos) e 149 eram do sexo masculino (p>0,05). A COVID-19 foi detectada em cinco pacientes no grupo BCG e em um no grupo controle (p>0,05). CONCLUSÃO A administração intravesical de BCG não diminui a frequência da infecção por COVID-19.
Subject(s)

Fulltext
Print
XML
Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / BCG Vaccine / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Risk factors Limits: Aged / Aged80 / Humans / Male Language: English Journal: Rev Assoc Med Bras (1992) Year: 2020 Type: Article Institution/Affiliation country: Sakarya University/TR

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Pneumonia, Viral / BCG Vaccine / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Risk factors Limits: Aged / Aged80 / Humans / Male Language: English Journal: Rev Assoc Med Bras (1992) Year: 2020 Type: Article Institution/Affiliation country: Sakarya University/TR